Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus
Titel:
Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus
Auteur:
Hussey, Elizabeth K Kapur, Anita O’Connor-Semmes, Robin Tao, Wenli Rafferty, Bryan Polli, Joseph W James, Charles D Dobbins, Robert L